Endothelial progenitor cells (EPCs) are believed to play an important role in the injury response of the human vasculature. Sudies have shown how EPCs are activated and play roles in tumor and hindlimb ischemia nevascularization[1,2]. Furthermore, EPCs are increased after surgical procedures and localized to vascular grafts and denuded arteries[2,3]. EPCs have also garnered immense interest in the field of tissue engineering due to their ease of isolation and their high prolifierative rate[2].

This content is only available via PDF.
You do not currently have access to this content.